Harmen Beurmanjer

108 References Bosch, O. G., Eisenegger, C., Gertsch, J., von Rotz, R., Dornbierer, D., Gachet, M. S., … Quednow, B. B. (2015). Gam- ma-hydroxybutyrate enhances mood and prosocial behavior without affecting plasma oxytocin and testosterone. Psychoneuroendocrinology , 62 , 1–10. https://doi.org/10.1016/j.psyneuen.2015.07.167 Bosch, O. G., Havranek, M. M., Baumberger, A., Preller, K. H., von Rotz, R., Herdener, M., …Quednow, B. B. (2017). Neural underpinnings of prosexual effects induced by gamma-hydroxybutyrate in healthy male humans. European Neuropsychopharmacology , 27 (4), 372–382. https://doi.org/10.1016/j.euroneuro.2017.02.006 Bosch, O. G., & Seifritz, E. (2016). The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humans. Brain Research Bulletin , Vol. 126, pp. 47–60. https://doi.org/10.1016/j.brainresbull. 2016.02.002 Bourne A, Reid D, Hickson F, Torres Rueda S, W. P. (2014). The Chemsex study: drug use in sexual settings among gay & bisexual men in Lambeth, Southwark & Lewisham. In 2014 . https://doi.org/978-1-906673-18-5 Brenneisen, R., ElSohly, M. A., Murphy, T. P., Passarelli, J., Russmann, S., Salamone, S. J., & Watson, D. E. (2004). Pharma- cokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects. Journal of Analytical Toxicology , 28 (8), 625–630. https://doi.org/10.1093/jat/28.8.625 Bruijnen, C. J. W. H., Dijkstra, B. A. G., Walvoort, S. J. W., Markus, W., VanDerNagel, J. E. L., Kessels, R. P. C., & DE Jong, C. A. J. (2019). Prevalence of cognitive impairment in patients with substance use disorder. Drug and Alcohol Review , 38 (4), 435–442. https://doi.org/10.1111/dar.12922 Bruijnen, C. J. W. H., Jansen, M., Dijkstra, B. A. G., Walvoort, S. J. W., Lugtmeijer, S., Markus, W., … Kessels, R. P. C. (2019). The Montreal Cognitive Assessment (MoCA) as a cognitive screen in addiction health care: A validation study for clinical practice. Journal of Substance Use , 24 (1), 47–54. https://doi.org/10.1080/14659891.2018.1497102 Brunt, T., & Schrooten, J. (2014). GHB-epidemiologie in Nederland en Vlaanderen. Verslaving : Tijdschrift over Verslav- ingsproblematiek , 10 (3), 20–32. https://doi.org/10.1007/s12501-014-0025-3 Brunt, T M, van Amsterdam, J. G. C., & van den Brink, W. (2014). GHB, GBL and 1,4-BD addiction. Current Pharmaceutical Design , 20 (25), 4076–4085. https://doi.org/10.2174/13816128113199990624 Brunt, Tibor M., Koeter, M. W., Hertoghs, N., van Noorden, M. S., & van den Brink, W. (2013). Sociodemographic and substance use characteristics of gamma hydroxybutyrate (GHB) dependent inpatients and associations with dependence severity. Drug and Alcohol Dependence , 131 (3), 316–319. https://doi.org/10.1016/j.drugalcdep. 2012.12.023 Busardo, F., & Jones, A. (2015). GHB Pharmacology and Toxicology: Acute Intoxication, Concentrations in Blood and Urine in Forensic Cases and Treatment of the Withdrawal Syndrome. Current Neuropharmacology , 13 (1), 47–70. https://doi.org/10.2174/1570159X13666141210215423 Busardò, F. P., Kyriakou, C., Napoletano, S., Marinelli, E., & Zaami, S. (2015). Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome. European Review for Medical and Pharmacological Sciences , 19 (23), 4654–4663. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26698265 Carter, L. P., Griffiths, R. R., & Mintzer, M. Z. (2009). Cognitive, psychomotor, and subjective effects of sodiumoxybate and triazolam in healthy volunteers. Psychopharmacology , 206 (1), 141–154. https://doi.org/10.1007/s00213-009-1589-1 Carter, L. P., Pardi, D., Gorsline, J., & Griffiths, R. R. (2009). Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodiumoxybate (Xyrem®): Differences in characteristics andmisuse. Drug andAlcohol Dependence , Vol. 104, pp. 1–10. https://doi.org/10.1016/j.drugalcdep.2009.04.012 Castelli, M. P., Mocci, I., Langlois, X., Gommeren, W., Luyten, W. H. M. L., Leysen, J. E., & Gessa, G. L. (2000). Quantitative autoradiographic distribution of γ-hydroxybutyric acid binding sites in human and monkey brain. Molecular Brain Research . https://doi.org/10.1016/S0169-328X (00)00078-4 Chan, R. C. H., & Mak, W. W. S. (2016). Common sense model of mental illness: Understanding the impact of cognitive and emotional representations of mental illness on recovery through the mediation of self-stigma. Psychiatry Research , 246 , 16–24. https://doi.org/10.1016/j.psychres.2016.09.013 Chaudhuri, R., & Fiete, I. (2016). Computational principles of memory. Nature Neuroscience . https://doi.org/10.1038/ nn.4237 Coenen, N. C. B., Dijkstra, B. A. G., Batalla, A., & Schellekens, A. F. A. (2019). Detoxification of a Patient with Comorbid Dependence on Phenibut and Benzodiazepines by Tapering with Baclofen: Case Report. Journal of Clinical Psychopharmacology . https://doi.org/10.1097/JCP.0000000000001104 Corkery, J. M., Loi, B., Claridge, H., Goodair, C., Corazza, O., Elliott, S., & Schifano, F. (2015). Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK